Results 81 to 90 of about 1,313 (167)

Questionnaire-based epidemiological survey of primary focal hyperhidrosis and survey on current medical management of primary axillary hyperhidrosis in Japan. [PDF]

Arch Dermatol Res, 2023
Fujimoto T, Inose Y, Nakamura H, Kikukawa Y.   +3 more
europepmc   +1 more source

Topical glycopyrronium tosylate in Japanese patients with primary axillary hyperhidrosis: A randomized, double-blind, vehicle-controlled study. [PDF]

J Dermatol, 2022
Yokozeki H, Fujimoto T, Wanatabe S, Ogawa S, Fujii C.   +4 more
europepmc   +1 more source

Axillary hyperhidrosis. [PDF]

BMJ, 1970
openaire   +2 more sources

Impostor phenomenon is a common feature among individuals with primary hyperhidrosis

SAGE Open Medicine
Background: Primary hyperhidrosis consists of excessive focal sweating. Affected individuals camouflage the sweating on their body, avoiding stigmatisation.
Alexander Shayesteh, Jens Boman, Elisabet Nylander   +2 more
doaj   +1 more source

Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis. [PDF]

Clin Pharmacokinet, 2021
Pariser DM, Lain EL, Mamelok RD, Drew J, Mould DR.   +4 more
europepmc   +1 more source

Real-World Outcomes of Microwave Treatment for Axillary Hyperhidrosis and Bromhidrosis: A 12-Month Study in a Southeast Asian Setting

Clinical, Cosmetic and Investigational Dermatology
Thu Tran Minh Le,1,* Ngocbich T Dang,2,* Trung The Van11Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; 2Department of Dermatology and Aesthetic Dermatology, Tam Anh General ...
Le TTM, Dang NT, Van TT
doaj  

Treatment of axillary hyperhidrosis [PDF]

BMJ, 1980
G R Bailie, A R Gibson, R J Williamson
  +5 more sources

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. [PDF]

Br J Dermatol, 2021
Abels C, Soeberdt M, Kilic A, Reich H, Knie U, Jourdan C, Schramm K, Heimstaedt-Muskett S, Masur C, Szeimies RM.   +9 more
europepmc   +1 more source

Compensatory hyperhidrosis following microwave-based therapy for axillary hyperhidrosis. [PDF]

JAAD Case Rep
Lim D, Hang XC.
europepmc   +1 more source

A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. [PDF]

J Dermatol, 2021
Fujimoto T, Abe Y, Igarashi M, Ishikoh A, Omi T, Kanda H, Kitahara H, Kinoshita M, Nakasu I, Hattori N, Horiuchi Y, Maruyama R, Mizutani H, Murakami Y, Watanabe C, Kume A, Hanafusa T, Hamaguchi M, Yoshioka A, Egami Y, Matsuo K, Matsuda T, Akamatsu M, Yorozuya T, Takayama S, Yokozeki H.   +25 more
europepmc   +1 more source